Posts

Moderna raises growth outlook as vaccine sales and newer products gain momentum

on

Ziltivekimab lowered inflammation markers, but ZEUS found no cardiovascular-event benefit

on

Moderna’s COVID vaccine sales power a Q3 revenue beat

on

Chai Discovery adds Roche to its AI drug-discovery partnerships

on

FDA expands J&J’s Rybrevant Faspro beyond lung cancer

on

Novartis reports seven newly disclosed tumor cases among Zolgensma patients

on

GeneDx and Mirum launch no-cost genetic testing programs

on

Inovia Bio launches InovaMine for clinical data analysis and drug development

on

AstraZeneca reportedly offers about $10B for Rhythm

on

Evommune licenses Hinova’s VAV1 drug candidate in deal worth up to $1.1 billion

on

RASONQUE brings in nearly $198 million in its first five weeks

on

Minghui licenses Japan rights to TED drug for $110M upfront

on

Ultragenyx to cut about 20% of staff and discontinue Wilson disease gene therapy

on